Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
nasha hyaluronic acid
- Development stage
- Unknown
- Lead developer
- Bioventus
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Intraarticular, Subcutaneous, Intradermal
01
Overview
NASHA hyaluronic acid is a stabilized, non-animal-derived hyaluronic acid produced via biotechnological fermentation, engineered for prolonged residence time and improved stability in tissue. It forms a clear, viscous gel used for intra-articular injection (notably in a single-dose regimen) as viscosupplementation in osteoarthritis, providing symptom relief and improved joint mobility. NASHA hyaluronic acid is also used as a dermal filler for correction of facial wrinkles, folds, and lip augmentation. Its mechanism is largely physical—providing volume, lubrication, and cushioning through integration with local tissue and water, rather than direct pharmacological receptor interaction[1][2][3][6][7][9].
- Brand names
- DurolaneRestylane
- Other names
- non-animal stabilized hyaluronic acidNASHA HANASHA hyaluronate
02
Targets
CD44 (CD44 antigen)
Beyond the preview
Go deeper on nasha hyaluronic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on nasha hyaluronic acid.